Effect of Selenium on Ischemia-Reperfusion Injury in the Coronary Artery Bypass Graft Surgery: A Clinical Trial Study-Reference-Cited by-同舟云学术

Effect of Selenium on Ischemia-Reperfusion Injury in the Coronary Artery Bypass Graft Surgery: A Clinical Trial Study

Published:2016-12-11 Issue:4 Volume:19 Page:
ISSN:2074-1804
Container-title:Iranian Red Crescent Medical Journal
language:
Short-container-title:Iran Red Crescent Med J

Author:

Sedighinejad Abbas,Imantalab Vali,Mirmansouri Ali,Mohammadzadeh Jouryabi Ali,Nassiri Sheikhani Nassir,Naderi Nabi Bahram,Haghighi Mohammad,Biazar Gelareh,Atrkarroushan Zahra

Publisher

DoNotEdit

Subject

General Medicine

Reference50 articles.

1. Eplerenone does not limit ischemia–reperfusion injury in human myocardial tissue

2. Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery

3. Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

4. Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro

5. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative selenium administration in cardiac surgery patients, a way out to reduce post surgical adversities? A meta analysis;Frontiers in Cardiovascular Medicine;2023-08-29

2. Relationship Between Selenium Trace and Patient Outcome After Open-Heart Surgery;Anesthesiology and Pain Medicine;2020-08-09

3. Effect of Selenium Added to the Cardioplegic Solution on Cardiac Protection in Coronary Artery Bypass Grafting Surgeries: A Randomized, Double-Blinded, Clinical Trial Study;Iranian Red Crescent Medical Journal;2019-10-21

4. Efficacy of Dexmedetomidine in Coronary Artery Bypass Graft Surgery under Cardiopulmonary Bypass: A Randomized, Double-Blind Clinical Trial;Iranian Red Crescent Medical Journal;2018-09-10